Antimicrobial potential of probiotic or potentially probiotic lactic acid bacteria, the first results of the International European Research Project PROPATH of the PROEUHEALTH cluster

Microbial Ecology in Health and Disease

Volumn 16, Issue 2-3, 2004, Pages 125-130

  De Vuyst, Luc ^a   Makras, Lefteris ^a   Avonts, Lazlo ^a   Holo, Helge ^a   Yi, Qing ^a   Servin, Alain ^a   Fayol Messaoudi, Domitille ^a   Berger, Cédric ^a   Zoumpopoulou, Georgia ^a   Tsakalidou, Effie ^a   Sgouras, Dionyssios ^a   Martinez Gonzales, Beatriz ^a   Panayotopoulou, Effie ^a   Mentis, Andreas ^a   Smarandache, Diana ^a   Savu, Lorand ^a   Thonart, Philippe ^a   Nes, Ingolf ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Antimicrobial agents; Gastrointestinal pathogens; Probiotics

Indexed keywords

ANTIINFECTIVE AGENT; CARBOXYLIC ACID; PREBIOTIC AGENT; PROBIOTIC AGENT;

BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BREAST FEEDING; BREAST MILK; CONFERENCE PAPER; DRUG EFFECT; DRUG IDENTIFICATION; DRUG SCREENING; EUROPE; EVIDENCE BASED MEDICINE; FECES; FERMENTATION; FOOD; GASTROINTESTINAL DISEASE; HELICOBACTER PYLORI; LABORATORY; LACTIC ACID BACTERIUM; NONHUMAN; PRIORITY JOURNAL; SALMONELLA ENTERICA; TIME;

ANIMALIA; BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI; NEGIBACTERIA; SALMONELLA; SALMONELLA ENTERICA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

EID: 3342941829     PISSN: 0891060X     EISSN: None     Source Type: Journal    
DOI: 10.1080/08910600410032303     Document Type: Conference Paper

References (32)

1. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512-9.
2. Holzapfel WH, Haberer P, Snel J, Schillinger U, Huis in't Veld JH. Overview of gut flora and probiotics. Int J Food Microbiol 1998; 41: 85-101.
3. Gomes AMP, Malcata FX. Bifidobacterium spp. and Lactobacillus acidophilus: biological, biochemical, technological and therapeutical properties relevant for use as probiotics. Trends Food Sci Tech 1999; 10: 139-57.
4. Mercenier A, Pavan S, Pot B. Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr Pharm Des 2003; 9: 175-91.
5. De Vuyst L, Avonts L, Makras L. Probiotics, prebiotics and gut health. In: Remacle C, Reusens B, eds. Functional Foods, Ageing and Degenerative Disease. Cambridge: Woodhead Publishing, 2004 (in press).
6. Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr 2001; 73: 430S-6S.
7. Michetti P, Dorta G, Wiesel PH, Brassart D, Verdu E, Herranz M, Felley C, Porta N, Rouvet M, Blum AL, Corthesy-Theulaz I. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 1999; 60: 203-9.
8. Felley CP, Corthesy-Theulaz I, Rivero JL, Sipponen P, Kaufmann M, Bauerfeind P, Wiesel PH, Brassart D, Pfeifer A, Blum AL, Michetti P. Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur J Gastroenterol Hepatol 2001; 13: 25-9.
9. Gotteland M, Cruchet S. Suppressive effect of frequent ingestion of Lactobacillus johnsonii La1 on Helicobacter pylori colonization in asymptomatic volunteers. J Antimicrob Chemother 2003; 51: 1317-9.
10. Pipkin GA, Williamson R, Wood JR. One-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori. Aliment Pharmacol Ther 1998; 12: 823-37.
11. Finlay BB, Falkow S. Salmonella interactions with polarized human intestinal Caco-2 epithelial cells. J Infect Dis 1990; 162: 1096-106.
12. Pot B, Vandamme P, Kersters K. Analysis of electrophoretic whole-organism protein fingerprints. In: Goodfellow M, O'Donnel AG, eds. Modern Microbial Methods. Chemical Methods in Prokaryotic Systematics. Chichester, UK: J Wiley and Sons, 1994.
13. Tilsala-Timisjarvi A, Alatossava T. Development of oligonucleotide primers from the 16S-23S rRNA intergenic sequences for identifying different dairy and probiotic lactic acid bacteria by PCR. Int J Food Microbiol 1997; 35: 49-56.
14. Utaker JB, Bakken L, Jiang QQ, Nes IF. Phylogenetic analysis of seven new isolates of ammonia-oxidizing bacteria based on 16S rRNA gene sequences. Syst Appl Microbiol 1995; 18: 549-59.
15. De Vuyst L, Callewaert R, Pot B. Characterization of the antagonistic activity of Lactobacillus amylovorus DCE 471 and large scale isolation of its bacteriocin amylovorin L471. Syst Appl Microbiol 1996; 19: 9-20.
16. Tagg JR, McGiven AR. Assay system for bacteriocins. Appl Microbiol 1971; 21: 943.
17. Flamm RK, Beyer J, Tanaka SK, Clement J. Kill kinetics of antimicrobial agents against Helicobacter pylori. J Antimicrob Chemother 1996; 38: 719-25.
18. Bernet-Camard MF, Lievin V, Brassart D, Neeser JR, Servin AL, Hudault S. The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl Environ Microbiol 1997; 63: 2747-53.
19. De Vuyst L, Vandamme EJ. Bacteriocins of Lactic Acid Bacteria. Microbiology, Genetics and Applications. London: Blackie Academic and Professional, 1994.
20. Klaenhammer TR. Bacteriocins of lactic-acid bacteria. Biochimie 1988; 70: 337-49.
21. Kalchayanand N, Sikes T, Dunne CP, Ray B. Hydrostatic-pressure and electroporation have increased bactericidal efficiency in combination with bacteriocins. Appl Environ Microbiol 1994; 60: 4174-7.
22. Luders T, Birkemo GA, Fimland G, Nissen-Meyer J, Nes IF. Strong synergy between a eukaryotic antimicrobial peptide and bacteriocins from lactic acid bacteria. Appl Environ Microbiol 2003; 69: 1797-9.
23. Itoh T, Fujimoto Y, Kawai Y, Toba T, Saito T. Inhibition of food-borne pathogenic bacteria by bacteriocins from Lactobacillus gasseri. Lett Appl Microbiol 1995; 21: 137-41.
24. Kawai Y, Ishii Y, Uemura K, Kitazawa H, Saito T, Itoh T. Lactobacillus reuteri LA6 and Lactobacillus gasseri LA39 isolated from faeces of the same human infant produce identical cyclic bacteriocin. Food Microbiol 2001; 18: 407-15.
25. Ramare F, Nicoli J, Dabard J, Corring T, Ladire M, Gueugneau AM, Raibaud P. Trypsin dependent production of an antibacterial substance by a human Peptostreptococcus strain in gnotobiotic rats and in vitro. Appl Environ Microbiol 1993; 59: 2876-83.
26. Bourlioux P. What is currently known about the molecular mechanisms of colonisation resistance. Anaerobe 1997; 3: 179-84.
27. Dabard J, Bridonneau C, Phillipe C, Anglade P, Molle D, Nardi M, Ladire M, Girardin H, Marcille F, Gomez A, Fons M. Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces. Appl Environ Microbiol 2001; 67: 4111-8.
28. Bernet MF, Brassart D, Neeser JR, Servin AL. Lactobacillus acidophilus La-1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 1994; 35: 483-9.
29. Coconnier MH, Lievin V, Bernet-Camard MF, Hudault S, Servin AL. Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB. Antimicrob Agents Chemother 1997; 41: 1046-52.
30. Coconnier MH, Lievin V, Lorrot M, Servin AL. Antagonistic activity of Lactobacillus acidophilus LB against intracellular Salmonella enterica serovar Typhimurium infecting human enterocyte-like Caco-2/TC-7 cells. Appl Environ Microbiol 2000; 66: 1152-7.
31. Silva M, Jacobus NV, Deneke C, Gorbach SL. Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother 1987; 31: 1231-3.
32. Hudault S, Lievin V, Bernet-Camard MF, Servin AL. Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl Environ Microbiol 1997; 63: 513-8.